Adicet Bio, Inc. (ACET)

Adicet Bio Statistics

Total Valuation

Adicet Bio has a market cap or net worth of $55.47 million. The enterprise value is -$78.73 million.

Market Cap	55.47M
Enterprise Value	-78.73M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Adicet Bio has 82.71 million shares outstanding. The number of shares has increased by 74.50% in one year.

Current Share Class	82.71M
Shares Outstanding	82.71M
Shares Change (YoY)	+74.50%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	1.67%
Owned by Institutions (%)	44.00%
Float	61.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.34
P/TBV Ratio	0.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.34, with a Debt / Equity ratio of 0.10.

Current Ratio	9.34
Quick Ratio	9.15
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-63,314.50

Financial Efficiency

Return on equity (ROE) is -55.83% and return on invested capital (ROIC) is -34.67%.

Return on Equity (ROE)	-55.83%
Return on Assets (ROA)	-32.68%
Return on Invested Capital (ROIC)	-34.67%
Return on Capital Employed (ROCE)	-72.43%
Revenue Per Employee	n/a
Profits Per Employee	-$771,842
Employee Count	152
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.59% in the last 52 weeks. The beta is 1.61, so Adicet Bio's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-55.59%
50-Day Moving Average	0.72
200-Day Moving Average	0.87
Relative Strength Index (RSI)	41.56
Average Volume (20 Days)	369,284

Short Selling Information

The latest short interest is 3.76 million, so 4.55% of the outstanding shares have been sold short.

Short Interest	3.76M
Short Previous Month	3.32M
Short % of Shares Out	4.55%
Short % of Float	6.13%
Short Ratio (days to cover)	8.91

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-126.63M
Pretax Income	-139.79M
Net Income	-117.32M
EBITDA	-120.13M
EBIT	-126.63M
Earnings Per Share (EPS)	-$1.29

Balance Sheet

The company has $150.44 million in cash and $16.25 million in debt, giving a net cash position of $134.19 million or $1.62 per share.

Cash & Cash Equivalents	150.44M
Total Debt	16.25M
Net Cash	134.19M
Net Cash Per Share	$1.62
Equity (Book Value)	161.45M
Book Value Per Share	1.95
Working Capital	137.12M

Cash Flow

In the last 12 months, operating cash flow was -$94.93 million and capital expenditures -$2.37 million, giving a free cash flow of -$97.30 million.

Operating Cash Flow	-94.93M
Capital Expenditures	-2.37M
Free Cash Flow	-97.30M
FCF Per Share	-$1.18

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adicet Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-74.50%
Shareholder Yield	-74.50%
Earnings Yield	-211.52%
FCF Yield	-175.42%

Analyst Forecast

The average price target for Adicet Bio is $5.60, which is 735.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.60
Price Target Difference	735.07%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-37.97%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1